CPCC Research Advocates for Diversity in Clinical Research Practices

May 1, 2024

Atlanta, Georgia – CPCC Research, a leading name in clinical research practices, underscores its commitment to promoting diversity within the industry. On April 6, 2024, CPCC Research Founder, Ngozika Orjioke, was invited to participate as a Panel Speaker at a prestigious event focused on diversity in clinical research practices.

The panel discussion, held on April 6, 2024, brought together prominent figures in the field to address the importance of diversity in clinical trials and research practices. Ngozika Orjioke, renowned for her expertise in clinical research methodologies, shared valuable insights and perspectives on the crucial role of diversity in advancing medical research.

“Diversity is not just a moral imperative; it is essential for the integrity and effectiveness of clinical research,” remarked Ngozika Orjioke during the panel discussion. “By ensuring diverse representation in our studies, we can better understand the nuances of disease manifestation across different populations and develop more inclusive treatments.”

CPCC Research stands at the forefront of advocating for diversity in clinical research practices. By actively participating in events like the April 6 panel discussion, the company reaffirms its dedication to fostering inclusivity and equity in the healthcare landscape.

The insights shared by Ngozika Orjioke and other panelists underscored the need for proactive measures to address disparities in clinical research participation. Through collaborative efforts and community engagement, CPCC Research aims to bridge the gap and promote equitable access to clinical trials for all populations.

As a company committed to excellence and innovation in clinical research, CPCC Research remains steadfast in its mission to drive positive change and advance medical science through diversity and inclusion.

[About CPCC Research] CPCC Research is a leading provider of clinical research services, dedicated to advancing medical science through rigorous research practices. With a focus on innovation, integrity, and inclusivity, CPCC Research strives to improve patient outcomes and contribute to the global healthcare community. 

April 3, 2024

CPCC Research Internal Summit Ignites Innovation and Growth for its Research Professionals

CPCC Research recently concluded its highly anticipated Internal Summit, an event designed to empower employees with invaluable opportunities for growth, networking, and knowledge exchange. With a focus on fostering leadership, mentorship, and skill enhancement, the summit proved to be a resounding success, leaving participants inspired and equipped to tackle industry challenges head-on.

The Internal Summit served as a dynamic platform for employees to engage with industry leaders, find mentors, and forge meaningful connections within their professional networks. By facilitating direct interaction with top executives and seasoned professionals, attendees seized the opportunity to glean insights, seek guidance, and establish mentor-mentee relationships that promise to drive personal and professional development.

“Our employees are the cornerstone of our success, and investing in their growth is paramount to our continued advancement in the field of clinical research,” remarked Ngozika Orjioke . “The Internal Summit provided a unique forum for our team to not only learn from industry luminaries but also to connect with peers, share experiences, and collaborate on innovative solutions.”

At the summit, participants immersed themselves in discussions on emerging industry trends, competitive landscapes, and best practices, empowering them to stay ahead of the curve and remain agile in a rapidly evolving environment. Through engaging workshops, thought-provoking presentations, and interactive sessions, employees honed their existing skills and acquired new ones, reinforcing their expertise and adaptability in the face of evolving challenges.

One of the highlights of the event was the opportunity for employees to present their ideas and projects to a panel of experts, receiving valuable feedback and validation from seasoned professionals. This unique aspect of the summit not only bolstered participants’ confidence but also provided a platform for collaborative innovation and knowledge sharing.

Keynote speakers at the Internal Summit captivated audiences with their insights, expertise, and thought-provoking perspectives, offering attendees a rare opportunity to gain profound insights and fresh ideas from leaders at the forefront of the industry. By harnessing diverse perspectives and fostering a culture of innovation, the summit empowered employees to approach challenges with creativity, resilience, and a renewed sense of purpose.

As CPCC Research continues to prioritize the growth and development of its workforce, the success of the Internal Summit underscores its commitment to nurturing talent, fostering collaboration, and driving excellence in clinical research.

Mark your calendars! We’re thrilled to invite you to the “Diversity in Clinical Trials Summit,” hosted by Sonar Groups LLC with our very own Ngozika Orjioke speaking. 

https://lnkd.in/dy_TSH3m

This event is not just an opportunity; it’s a crucial step towards bridging gaps and fostering inclusivity in healthcare research. 

At this summit, we’re diving deep into the impact of African Americans and minorities on clinical trials. From historical context to present-day initiatives, we’ll explore:
Panel Discussion I: Understanding the Historical Context
Panel Discussion II: Addressing Current Challenges and Opportunities
Safety in Clinical Trials: Ensuring Inclusive Participation

Here’s a sneak peek into the topics we’ll be covering:
What’s being done to ensure safe participation of minorities in clinical trials by the FDA, Pharmaceutical companies, and clinicians?
Identifying and addressing obstacles and myths that hinder African Americans and minorities from participating in clinical trials.
Understanding the differences between routine office visits and clinical trial visits.

This isn’t just a discussion; it’s a call to action. By coming together, sharing insights, and fostering dialogue, we can drive meaningful change in the landscape of clinical research. 
Don’t miss out on this opportunity to be a part of the solution. Reserve your spot today and let’s pave the way for a more inclusive and impactful future in healthcare! 

CPCC-RESEARCH

Clinical trials play a pivotal role in advancing medical knowledge and improving outcomes for asthma patients. By participating in clinical trials, asthma patients contribute to the development and evaluation of new treatments, medications, and interventions aimed at better managing asthma symptoms and preventing exacerbations. These trials provide researchers with valuable insights into the effectiveness and safety of potential therapies, ultimately leading to the development of more targeted and personalized treatment approaches. Additionally, participation in clinical trials empowers patients by offering access to cutting-edge treatments and the opportunity to play an active role in shaping the future of asthma care. Through collaborative efforts between researchers, healthcare professionals, and patients, clinical trials pave the way for innovative advancements that can enhance the quality of life for individuals living with asthma.

[Embargoed until April 1, 2024]

FOR IMMEDIATE RELEASE

Contact: Sonar Groups LLC Email: info@sonargroups.com Phone: (123) 456-7890

“Diversity In Clinical Trials Summit” to Illuminate Crucial Healthcare Discussions

Atlanta, GA – March 15, 2024 – Sonar Groups LLC proudly announces the inaugural “Diversity In Clinical Trials Summit,” scheduled to take place on Saturday, April 6, at 1:00 PM at 384 Northyards Blvd NW, Atlanta, GA.

This landmark event seeks to shed light on the critical importance of diversity in clinical trials and its profound impact on healthcare outcomes. With a focus on empowering underrepresented communities, the summit will feature insightful discussions led by esteemed industry experts, including keynote speaker Dr. Ngozika Orjioke.

“The Diversity In Clinical Trials Summit aims to educate and engage our community on the pivotal role of participation in clinical research,” said Dr. Orjioke, a renowned advocate for health equity and inclusivity. “By addressing barriers, dispelling myths, and fostering dialogue, we can pave the way for a more equitable and impactful future in healthcare.”

The agenda for the summit includes:

  • Panel Discussion I: Unveiling the Historical Context
  • Panel Discussion II: Navigating Current Challenges and Opportunities
  • Safety in Clinical Trials: Ensuring Equitable Participation

Attendees will have the opportunity to participate in an open panel discussion focused on the impact of African Americans and minorities on clinical trials. Key topics of exploration include the FDA and pharmaceutical companies’ efforts to ensure the safe participation of minorities, as well as identifying and addressing obstacles that prevent participation.

“We believe that by coming together and sharing insights, we can drive meaningful change in the landscape of clinical research,” said a spokesperson for Sonar Groups LLC. “The Diversity In Clinical Trials Summit is not just a forum for discussion; it’s a catalyst for action and transformation.”

The event is open to healthcare professionals, researchers, community leaders, and individuals passionate about advancing health equity and inclusivity. Limited seating is available, and interested participants are encouraged to register early to secure their spot.

For more information and to register for the Diversity In Clinical Trials Summit, visit [Event Website].

About Sonar Groups LLC: Sonar Groups LLC is a leading organization dedicated to advancing health equity and inclusivity through innovative research, advocacy, and education. Committed to empowering underrepresented communities, Sonar Groups LLC strives to bridge gaps and drive positive change in the healthcare landscape.

 

[Note to Editors: High-resolution images and additional information are available upon request. For media inquiries or interview requests, please contact Sonar Groups LLC at info@sonargroups.com or (123) 456-7890.]

CPCC-RESEARCH

January 11, 2024

Covenant Pulmonary Critical Care & Covenant Pulmonary Research Reflects on our Successful November 2023 Community Wellness Fair

Covenant Pulmonary Critical Care & Covenant Pulmonary Research proudly looks back on the success of its Community Wellness Fair, which took place on November 2023 at East Point, GA. The event, dedicated to promoting respiratory health and overall well-being, drew a substantial turnout from the community and marked a significant step towards fostering a healthier populace.

The November 2023 Community Wellness Fair was a resounding success, bringing together community members, healthcare professionals, and local organizations with a shared commitment to respiratory health. The event featured a range of engaging activities and educational initiatives aimed at empowering attendees to prioritize their lung health.

Key highlights and accomplishments from the event include:

Community Engagement: The fair attracted a diverse crowd, including individuals of all ages and backgrounds, fostering a sense of community and shared responsibility for health and wellness.

Health Screenings: Numerous attendees took advantage of the complimentary health screenings provided by the Lungs Clinic’s dedicated healthcare professionals. These screenings offered valuable insights into individual respiratory health and encouraged proactive healthcare management.

Educational Success: Workshops led by respiratory health experts proved to be highly informative, covering topics such as smoking cessation, pollution awareness, and lifestyle choices that impact lung health. Participants left with a deeper understanding of how to make informed decisions for better respiratory well-being.

Interactive Exhibits: Hands-on exhibits allowed attendees to explore the importance of clean air, exercise, and nutrition for respiratory health. The interactive nature of these displays enhanced the learning experience and left a lasting impact on participants.

Community Resources: Local organizations and support groups actively participated, providing attendees with access to valuable resources and information on ongoing respiratory health support within the community.

Spelman Clinical Research Workshop: Hosted by  Covenant Pulmonary Research. 

November 6, 2023

Historically, Black women have been underrepresented in clinical trials. For example, only 3 percent of participants in clinical trials that led to Food and Drug Administration (FDA) approval of cancer drugs between 2008 and 2018 were Black. Additionally, when we look at the history of clinical trials, specifically the standard of care for Black women in trials, there can be minimal consideration on how specific drugs work with our bodies and genotypes.

Through this community engagement series at higher education institutions, Dr Orjioke hopes to encourage women of color to consider a career in clinical research, through volunteer opportunities and internships.

We hope to educate and empower by educating your student on the following:

  • The things that happened 50 years ago can’t happen now — there are laws in place to protect you when you participate in clinical trials.
  • This is a viable and potentially life saving option for many Black women, a career in clinical research is advocacy.
  • When you participate in a clinical trial, you have better outcomes because you get more supervision from doctors, more scans, more treatment, and more blood work.
  • Because we don’t have enough data on the current drugs for Black women, any time a Black woman gets treatment, she could be doing a clinical trial on her own body.
Clinical trials can save the lives of people in our communities. We hope that this series can help more women of color to consider participating in clinical research as a career pathway or as a research participant.

We would like to thank Spelman College for kicking off our research series!

Spelman Clinical Research Workshop: Hosted by  Covenant Pulmonary Research. 

November 6, 2023

Historically, Black women have been underrepresented in clinical trials. For example, only 3 percent of participants in clinical trials that led to Food and Drug Administration (FDA) approval of cancer drugs between 2008 and 2018 were Black. Additionally, when we look at the history of clinical trials, specifically the standard of care for Black women in trials, there can be minimal consideration on how specific drugs work with our bodies and genotypes.

Through this community engagement series at higher education institutions, Dr Orjioke hopes to encourage women of color to consider a career in clinical research, through volunteer opportunities and internships.

We hoped to educate and empower by educating students on the following:

  • The things that happened 50 years ago can’t happen now — there are laws in place to protect you when you participate in clinical trials.
  • This is a viable and potentially life saving option for many Black women, a career in clinical research is advocacy.
  • When you participate in a clinical trial, you have better outcomes because you get more supervision from doctors, more scans, more treatment, and more blood work.
  • Because we don’t have enough data on the current drugs for Black women, any time a Black woman gets treatment, she could be doing a clinical trial on her own body.

Clinical trials can save the lives of people in our communities. We would like to thank Spelman College for kicking off our research series!

Spelman Clinical Research Workshop: Hosted by  Covenant Pulmonary Research. 

November 6, 2023

Historically, Black women have been underrepresented in clinical trials. For example, only 3 percent of participants in clinical trials that led to Food and Drug Administration (FDA) approval of cancer drugs between 2008 and 2018 were Black. Additionally, when we look at the history of clinical trials, specifically the standard of care for Black women in trials, there can be minimal consideration on how specific drugs work with our bodies and genotypes.

Through this community engagement series at higher education institutions, Dr Orjioke hopes to encourage women of color to consider a career in clinical research, through volunteer opportunities and internships.

We hope to educate and empower by educating your student on the following:

  • The things that happened 50 years ago can’t happen now — there are laws in place to protect you when you participate in clinical trials.
  • This is a viable and potentially life saving option for many Black women, a career in clinical research is advocacy.
  • When you participate in a clinical trial, you have better outcomes because you get more supervision from doctors, more scans, more treatment, and more blood work.
  • Because we don’t have enough data on the current drugs for Black women, any time a Black woman gets treatment, she could be doing a clinical trial on her own body.
Clinical trials can save the lives of people in our communities. We hope that this series can help more women of color to consider participating in clinical research as a career pathway or as a research participant.

We would like to thank Spelman College for kicking off our research series!